Cure Kids Ventures
Venture capitalAuckland · Seed–Growth · 6 people tracked
Investment thesis
Cure Kids Ventures invests in early-stage biotech, healthcare and medical device opportunities, with a mission-driven focus on commercialising research and technologies that can improve child health. The team combines skills in early-stage company development, intellectual property commercialisation, global expansion, science, finance and mergers and acquisitions.
Source: firm website, verified Aug 2, 2026.
Team · 6 people
from the firm's websiteInvestment professional with 18 years of international venture capital experience across direct investments, fund of funds, portfolio management and divestments, with a focus on healthtech; she first worked with Cure Kids Ventures in 2014 and rejoined in 2025.
Recognised CEO, chair and director and founding CEO of the New Zealand Venture Investment Fund; she brings extensive governance experience across finance, technology and health, and chairs the Cure Kids Board.
Board member at Cure Kids Ventures since 2008 with experience across venture capital, agritech, foodtech and biotech; co-founder of Tercica, former executive director of BioPacific Ventures, and currently CEO of CKV investee Pictor Limited.
Investor and operator with twenty years' experience in New Zealand high-growth industries, including foundation team at No 8 Ventures and roles at BioDiscovery NZ, Callaghan Innovation and WaikatoLink where he led commercialisation across healthtech, AI, hardware and cyber security.
Board director with more than 20 years in the global medical device industry, including senior leadership at Fisher & Paykel Healthcare; he also serves on the board of Ossis Orthopaedics.
Director of the Auckland Bioengineering Institute and board director at Cure Kids Ventures, leading research in computational physiology of the respiratory system, and a Fellow of the Royal Society of New Zealand.
Investments · 19 tracked
founders shown can be your intro pathDunedin-based biotech developing a new class of therapeutics targeting lncRNA in cancer.
Developing next-generation implantable medical devices for pressure monitoring.
Data-driven wellbeing platform empowering students and enabling schools to make effective interventions.
Medical device company using laser verification to prevent injury and death from IV medication errors in hospitals.
Portable MRI enabling rapid diagnosis and monitoring for stroke and detection of hypoxic-ischemic encephalopathy in newborns.
Frequently asked questions
- What stage does Cure Kids Ventures invest at?
- Cure Kids Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Cure Kids Ventures focus on?
- Cure Kids Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Cure Kids Ventures located?
- Cure Kids Ventures is headquartered in Auckland, NZ.
Similar investors
Amadeus Capital Partners is a technology investor. It held a first close of $75M on its Amadeus IV Digital Prosperity Fund, focused on late-stage venture and growth companies building online and mobile services for emerging-market middle classes.
B Capital Group is a multistage venture capital firm that invests from seed to late stage, offering value-added support to founders in partnership with management consulting firm BCG.
Breyer Capital is a venture capital firm founded and led by Jim Breyer, headquartered in Austin, Texas, focused on long-term entrepreneurs in AI, quantum technology, and computation-driven healthcare and life sciences.
Capricorn Venture Partners is a Belgium-based venture capital firm managing several funds across health, cleantech, digital, and fusion sectors, accepting pitches from companies raising capital.
DCVC (Data Collective) is a deep tech venture capital firm backing entrepreneurs using computational approaches to solve large real-world problems across many industries. It operates six flagship funds plus DCVC Bio, spanning 13 funds to date.